US › Healthcare

ABVC Biopharma Inc (ABVC)

US · Healthcare · Biotechnology

$1.07+2.88%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-1.6M
Profit YoY
-85.3%
EPS
$-0.05
EPS estimate
$0.00

Key statistics

Market cap
$26.3M
Forward P/E
0.0
P/B
2.46
Book value
$0.43
EPS (TTM)
$-0.39
52-week high
$3.40
52-week low
$0.88
50-day MA
$1.35
200-day MA
$1.76
Beta
0.63

Analyst view

Analysts rate ABVC Biopharma Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $2.02.

Shareholding

Insiders
18.57%
Institutions
3.14%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.85%
Vanguard Capital Management, LLC0.73%
Vanguard Fiduciary Trust Co0.37%
Renaissance Technologies Corp0.37%
State Street Corp0.28%
BlackRock Inc0.22%
Northern Trust Corp0.12%
TWO SIGMA SECURITIES, LLC0.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for ABVC Biopharma Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.